Target intelligence / Profile preview

TFPI2 divergent transcript (TFPI2-DT)

Target
TFPI2-DT
Molecular classification
Other (long non-coding RNA, divergent transcript)
01

Overview

TFPI2 divergent transcript (TFPI2-DT) is a long non-coding RNA identified at the human genome locus associated with the TFPI2 gene. Unlike the well-characterized TFPI2 protein, which is a secreted Kunitz-type serine protease inhibitor and has established roles in tumor suppression, extracellular matrix remodeling, and diseases like cancer and thrombosis[1][5], the TFPI2-DT transcript does not code for protein and its biological or pathological significance is currently unclear in the scientific literature. The entry "TFPI2-DT" can be mistaken for the TFPI2 protein and should be referenced carefully[3]. Summary of Key Issues: - The term "TFPI2 divergent transcript" refers to a non-coding RNA with limited to no functional characterization. - Most published research and clinical relevance pertains to the protein-coding gene TFPI2, not TFPI2-DT. - It is not an established drug target and should not be conflated with TFPI2 protein in structured drug target databases[3].

Other names
NR_134235.1
02

Mechanism of action

Not applicable; no known drugs or molecules with mechanism of action targeting TFPI2-DT.

03

Biological functions

Unknown for TFPI2-DT itself. TFPI2-DT is not reported to have direct biological activities; its roles (if any) may be regulatory or yet to be characterized.
04

Disease associations

Other (no known established disease association for TFPI2-DT)

Beyond the preview

Go deeper on TFPI2 divergent transcript (TFPI2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TFPI2 divergent transcript (TFPI2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call